@article {LedfordS192, author = {C. J. W. Ledford and C. Roberts and E. Whisenant and C. Walters and K. Akamiro and J. Butler and A. Ali and D. A. Seehusen}, title = {Quantifying Worsened Glycemic Control During the COVID-19 Pandemic}, volume = {34}, number = {Supplement}, pages = {S192--S195}, year = {2021}, doi = {10.3122/jabfm.2021.S1.200446}, publisher = {The Journal of the American Board of Family Medicine}, abstract = {Aims: We hypothesized that glycemic control in outpatients, measured by HbA1c, was worse during the early months of the COVID-19 pandemic than in 2019. We sought to quantify how much worse and to determine if social determinants of health were associated with these differences.Materials and Methods: Data were extracted from the electronic medical records of 2 cohorts of patients seen in the family medicine clinic of a southeastern academic health center. Three hundred patients with baseline HbA1c results as well as HbA1c results in May 2019 or May 2020 were evaluated.Results: The groups had similar mean baseline HbA1c (7.65, SD = 1.50 for 2019; 7.61, SD = 1.71 for 2020; P = .85). Mean May HbA1c decreased from baseline in 2019 (7.19, SD = 1.45) but rose in 2020 (7.63, SD = 1.73), a statistically significant difference (P \< .01). Controlling for age, gender, race, and insurance status, HbA1c in May 2020 (meanadj = 7.73) was significantly higher than in May 2019 (meanadj = 7.16).Conclusions: During the early months of the COVID-19 pandemic, glycemic control in our patient population was significantly worse than during the same period in 2019 (mean HbA1c difference = 0.57). Contrary to our expectations, we did not find associations between patient demographic variables and glycemic control, including race.}, issn = {1557-2625}, URL = {https://www.jabfm.org/content/34/Supplement/S192}, eprint = {https://www.jabfm.org/content/34/Supplement/S192.full.pdf}, journal = {The Journal of the American Board of Family Medicine} }